Company Stellar Biotechnologies Inc Nasdaq
Equities
CA85855A2039
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 11/06/07 |
Michael Brooks
PSD | President | 46 | 31/08/15 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 14/07/23 |
Blair Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/16 |
Gary Koppenjan
IRC | Investor Relations Contact | - | 31/12/18 |
Raj Puri
PRN | Corporate Officer/Principal | - | 22/06/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 06/06/19 |
Frank Oakes
BRD | Director/Board Member | 73 | 08/04/10 |
Patrick Marshall
BRD | Director/Board Member | 53 | 22/05/23 |
Joan Chypyha
BRD | Director/Board Member | 57 | 22/05/23 |
Charles Olson
BRD | Director/Board Member | 66 | 22/05/23 |
Pardeep Nijhawan
FOU | Founder | 53 | 11/06/07 |
Carlo Sistilli
CHM | Chairman | 67 | 06/06/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,215,968 | 2,120,255 ( 65.93 %) | 0 | 65.93 % |
Company contact information
![address Stellar Biotechnologies Inc](https://cdn.zonebourse.com/static/address/24827071.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |